Articles, insights, and posts about Child Development, early detection, and new methods in diagnosis and treatment.
FDNA’s Year of Discovery Initiative will spotlight a different genetic syndrome group each month as part of their mission to accelerate advancements and discoveries for all rare diseases. Boston, MA. March 9, 2017— FDNA launched the Year of Discovery on February 28th, 2017 to unite clinicians, labs and patients for rare disease advancements. March, the […]
Annual Clinical Genetics Meeting (ACMG 2017) Phoenix Convention Center, Phoenix, Arizona March 21-25, 2017 Phoenix, Arizona – With ACMG just over a week away, the FDNA team is growing increasingly excited to trade in our winter coats and boots for sunshine and cacti. But the escape from the everlasting Boston winter aside, is the anticipation to […]
Dekel Gelbman, CEO of FDNA, was featured in the Medical Device and Diagnostics Industry, discussing the value of facial analysis technology and phenotyping in discovering rare disease diagnoses. Below is an excerpt: Diagnosing rare and ultra-rare genetic diseases can be extremely difficult for geneticists. The diagnostic odyssey, from the primary point of care, through the […]
Dekel Gelbman, CEO of FDNA, was featured in Becker’s Hospital Review, discussing the value of phenotyping to hospitals involved in rare disease workflows. Below is an excerpt: Diagnosing rare diseases is like solving a puzzle, with physicians trying to fit together many complex clues. Unfortunately, the 10% of the population who suffer from a rare […]
Boston-based health and tech start-up calls on patients and clinicians to share their stories to help make new discoveries needed to diagnose and treat rare genetic diseases February 28, 2017 09:00 AM Eastern Standard Time BOSTON–(BUSINESS WIRE)–Today, FDNA announces the launch of its Year of Discovery initiative. Beginning in March, the Year of Discovery initiative […]